January 2019 – Device is installed at MUSC 

July 2019- Breakthrough designation for Coma Study. 

August 2019- Breakthrough award from OCD Foundation awarded to MGH and Baylor.

December 2020- Safety study on 8 TR epilepsy subjects is completed and submitted.

July 2020- Pivotal trial for coma indication about to start.

July 2021 – Double Blind RCT for GAD starts at UCLA, MGH, and MUSC

PTSD study is about to start in Stanford, Palo Alto VA and Brown U, Providence VA about to embark on the PTSD and TBI study.